Association of
Northern California Oncologists
|
|
| ASH Highlights 2007 |
| ASH Highlights 2007 summarized the major research and treatment advancements presented at December 2007’s ASH Annual Meeting. The faculty focused on surgical, radiation, and medical oncology treatment modalities for hematological malignancies and placed these developments in context as to their immediate clinical utility. Educational Objectives. At the conclusion of this educational activity, participants were able to: • Review, summarize, and interpret important clinical results presented at the 2007 ASH Annual Meeting for surgical, radiation, and medical oncologists; oncology nurses; and, other health care professionals. • Comprehend and implement of changes in treatment for hematological malignancies. Target Audience. ASH Highlights 2007 was designed to meet the educational needs of oncologists, oncology nurses, primary care physicians, and other health care professionals involved in the care of people with hematological malignancies. Accreditation Statement and Designation of Credit. This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Indiana University School of Medicine and the Association of Northern California Oncologists (ANCO). The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Indiana University School of Medicine designated this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. The California Board of Registered Nurses accepts courses approved for AMA PRA Category 1 Credits as meeting the continuing education requirements for renewal. Disclosure Statement. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and Planning Committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. Acknowledgment of Commercial Support. Major support for this educational activity was provided by Bayer Healthcare Pharmaceuticals, biogenIDEC/Genentech BioOncology, and Celgene; additional support was provided by AMGEN, Alexion Pharmaceuticals, Bristol-Myers Squibb Oncology, Cephalon Oncology, Eisai, MGI Pharma, Millennium, Ortho Biotech, Pharmion, and Schering-Plough Oncology. Program Planning Committee. The Physician Course Director for ASH Highlights 2007 was Jeffrey L. Wolf, M.D., Univ. of California, San Francisco. Dr. Wolf was assisted by the ANCO Board of Directors (Richard A. Bohannon, M.D., Norman Cohen, M.D., Bradley Ekstrand, M.D., George A. Fisher, M.D., Ellie Guardino, M.D., Ph.D., Stephen T. Hufford, M.D., John A. Keech, Jr., D.O., L. Wayne Keiser, M.D., Daniel P. Mirda, M.D., Bimal J. Patel, M.D., Antoine Sayegh, M.D., and Peter Paul Yu, M.D.) and Institutional Member contacts (David Gandara, M.D., Primo Lara, M.D., and Margaret Tempero, M.D.) in the selection of the faculty for ASH Highlights 2007. Content Consultant. The Indiana University School of Medicine content consultant was Larry D. Cripe, M.D., Associate Professor of Hematology/Oncology. Download the presentations here: |